- Differential Diagnosis
- Try building your search one term at a time, and be as specific as you can! Search term example: "chronic cough".
- Do not enter multiple findings such as "anemia, chronic cough, weight loss, vomiting" all at the same time.
- After selecting your term from the search results a list of possible diagnoses will be generated. If the list is too long, you will be able to narrow it down by entering additional terms.
- Do not enter values such as "heart rhythm 110" or "sodium 125", instead use "tachycardia" or "hyponatremia".
- Disease Information
- Disease Comparison
Disease Processes ▼
- Auto Immune
- Infected Organ-Abcess
- Infectious agent
- Poison Agent
- Poisoned Organ
- Structural-Anatomic-Foreign body
- Surgical Procedure-Complication
Major Organs-Systems ▼
- Nervous & Sensory System (Neurology)
- Cardiovascular System
- Respiratory (Pulmonary) System
- Gastro-Intestinal (Digestive) System
- Urinary System
- Dermatologic System
- Endocrine System
- Immune System
- Musculoskeletal System
- Genital Reproductive System
- Hematopoietic System (Hematology)
- Lymphatic System
Disease Information for Staphylococcus aureus/CA-MRSA virulent PVL gene: Definition
Available only to registered users.
- 117 possible findings found
- Clinical Manifestations (23)
- Demographics & Risk Factors (10)
- Laboratory Tests (15)
- Diagnostic Test Results (4)
- Associated Diseases & Rule outs (38)
- Disease Mechanism & Classification (19)
- Treatment (8)
- External Links Related to Staphylococcus aureus/CA-MRSA virulent PVL gene
. Recently, a growing number of cases of MRSA infection acquired in the community (CA-MRSA infection) have been reported. Naimi and colleagues (2003) conducted a study based on an MRSA sentinel surveillance network in Minnesota, characterizing the demographic and clinical features of CA-MRSA and nosocomial MRSA infection and comparing the microbiological and molecular features of the two types of infection; Minnesota has 12 laboratory facilities that are surveillance sites for MRSA; 6 of these sites are in the 7-county Minneapolis-St. Paul metropolitan area. In 2000, all patients with MRSA isolates were identified, and infection-control practitioners reviewed their medical records.
In 2000, 4612 unique patients with S. aureus infections were identified, about one-quarter of whom had MRSA isolated; Of those patients, 85% had HA-MRSA infection, 12% had CA-MRSA infection, and 3% had unclassified infection; Patients with CA-MRSA infection were more likely to be nonwhite, were younger, and had a lower median household income than patients with HA-MRSA infection. Most cases of CA-MRSA infection involved skin and soft tissue; CA-MRSA infections were less likely to be respiratory or urinary tract infections than were HA-MRSA infections; Almost one-quarter of patients with CA-MRSA were hospitalized, and 5% required intensive care. More than 60% of CA-MRSA cases were first treated with a -lactam drug that was ineffective; CA-MRSA was more likely than HA-MRSA to be susceptible to other antimicrobial agents, particularly to all 4 of the following drugs: ciprofloxacin, clindamycin, gentamicin, and trimethoprim-sulfamethoxazole.
Of 16 exotoxin genes present in the MRSA isolates, 6 were significantly more likely to occur in CA-MRSA, including SCCmec IV (a gene that is probably more mobile than other SCCmec alleles), and 7 were significantly more likely to be found among HA-MRSA isolates; Panton Valentine leukocidin genes [PVL Genes] were found in 20 CA-MRSA isolates tested (77%) but in only 1 HA-MRSA isolate.
This report identifies important characteristics of CA-MRSA infections and compares those characteristics with those of HA-MRSA infections; Patients with CA-MRSA are more likely to be nonwhite, to be young, and to have skin and soft tissue infections; These bacterial strains are genetically distinct from HA-MRSA strains and probably arose independently; CA-MRSA strains are more likely to be susceptible to many agents, a characteristic suggesting that their emergence may be due to insertion of a mecA gene into a methicillin-susceptible strain of S aureus; Merck Medicus/harrison on line 7/05
suggested rx: trimethaprim-sulfasoxazole, cleocin, zyvox or vancomycin
very often after influenza or flu like illness then necrotizing pneumonia with low wbc but high bands with left shift. [pvl gene toxin lyses polys]